Commentary: Effects of psilocybin on time perception and temporal control of behavior in humans May 19, 2016
Prohibited or regulated? LSD psychotherapy and the United States Food and Drug Administration May 18, 2016
Ethical Considerations for Clinical Research and Off-label Use of Ketamine to Treat Mood Disorders: The Balance between Risks and Benefits May 17, 2016
Psilocybin with psychological support for treatment-resistant depression: An open-label feasibility study May 17, 2016
Mood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depression May 12, 2016
Glutamate and GABA Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine May 12, 2016
